menu
    • menu
    [{"orgOrder":0,"company":"University of California, San Francisco","sponsor":"Pan American Health Organization","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Primaquine Diphosphate","moa":"Plasmodium Deoxyribonucleic acid (Malaria DNA)","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III","graph3":"University of California, San Francisco","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"University of California, San Francisco \/ Pan American Health Organization","highestDevelopmentStatusID":"9","companyTruncated":"University of California, San Francisco \/ Pan American Health Organization"},{"orgOrder":0,"company":"Papua New Guinea Institute of Medical Research","sponsor":"Walter and Eliza Hall Institute | Swiss Tropical and Public Health Institute | Barcelona Centre for International Health Research","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"PAPUA NEW GUINEA","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Primaquine Diphosphate","moa":"Plasmodium Deoxyribonucleic acid (Malaria DNA)","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Papua New Guinea Institute of Medical Research","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Papua New Guinea Institute of Medical Research \/ Walter and Eliza Hall Institute | Swiss Tropical and Public Health Institute | Barcelona Centre for International Health Research","highestDevelopmentStatusID":"11","companyTruncated":"Papua New Guinea Institute of Medical Research \/ Walter and Eliza Hall Institute | Swiss Tropical and Public Health Institute | Barcelona Centre for International Health Research"},{"orgOrder":0,"company":"Menzies School of Health Research","sponsor":"Walter and Eliza Hall Institute | Ministry of Health, Vanuatu | Ministry of Health, Solomon Islands | World Health Organization","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"AUSTRALIA","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Primaquine Diphosphate","moa":"Plasmodium Deoxyribonucleic acid (Malaria DNA)","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Menzies School of Health Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Menzies School of Health Research \/ Walter and Eliza Hall Institute | Ministry of Health, Vanuatu | Ministry of Health, Solomon Islands | World Health Organization","highestDevelopmentStatusID":"1","companyTruncated":"Menzies School of Health Research \/ Walter and Eliza Hall Institute | Ministry of Health, Vanuatu | Ministry of Health, Solomon Islands | World Health Organization"}]

    Find Clinical Drug Pipeline Developments & Deals for Primaquine Diphosphate

    Menu

    Primaquine Diphosphate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            University of California, San Francisco

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            University of California, San Francisco

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Primaquine Diphosphate

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase II/ Phase III

                            Sponsor : Pan American Health Organization

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia

                            Details : Primaquine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Malaria, Vivax.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            February 09, 2022

                            Lead Product(s) : Primaquine Diphosphate

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase II/ Phase III

                            Sponsor : Pan American Health Organization

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Papua New Guinea Institute of Medical Research

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Papua New Guinea Institute of Medical Research

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Primaquine Diphosphate

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase IV

                            Sponsor : Walter and Eliza Hall Institute | Swiss Tropical and Public Health Institute | Barcelona Centre for International Health Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity

                            Details : Primaquine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Malaria, Vivax.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            May 21, 2014

                            Lead Product(s) : Primaquine Diphosphate

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase IV

                            Sponsor : Walter and Eliza Hall Institute | Swiss Tropical and Public Health Institute | Barcelona Centre for International Health Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Menzies School of Health Research

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Menzies School of Health Research

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Primaquine Diphosphate

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : Walter and Eliza Hall Institute | Ministry of Health, Vanuatu | Ministry of Health, Solomon Islands | World Health Organization

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety and Efficacy of Primaquine for P. Vivax

                            Details : Primaquine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Malaria.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            April 23, 2013

                            Lead Product(s) : Primaquine Diphosphate

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Walter and Eliza Hall Institute | Ministry of Health, Vanuatu | Ministry of Health, Solomon Islands | World Health Organization

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth